Whole exome sequencing analysis of 41 HCC tumours identifies distinct genomic alterations between RC1 and RC2 molecular clusters. (IMAGE)
Caption
(A) Oncoplot showing mutational profiles of driver genes (rows) across 41 HCC tumour samples (columns) ordered by race-associated clusters (RC1, RC2). Top barplot displays tumour mutation burden (TMB) per sample. Right barplot shows mutation frequency and percentage for each gene. Clinical annotations include race-associated cluster and race category (AA vs nonAA). (B) Nucleotide substitution signatures by molecular cluster. Mean proportion of each nucleotide change type shows similar mutational processes between RC1 and RC2. Error bars represent mean±SE. (C) Mutation frequencies for the top 5 genes with cluster specific enrichment (uncorrected p<0.100). SLC25A5 shows enrichment in RC2 (76%, 13/17) versus RC1 (42%, 10/24, p=0.054), while SGK3 shows enrichment in RC1 (38%, 9/24) versus RC2 (6%, 1/17, p=0.028). (D) Lollipop plot of SLC25A5 mutations displaying missense mutations (green circles) and nonsense mutations (orange circles) along with specific amino acid changes and their positions across the noted protein domains. (E) Lollipop plot of SGK3 mutations displaying missense mutations (green circles) along with specific amino acid changes and their positions across the noted protein domains. AA, African American; HCC, hepatocellular carcinoma; nonAA, non-African American.
Credit
By Aryan Neupane, Anuradha Budhu, Farid Rashidi Mehrabadi, et al.
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC